Drug intelligence / Profile preview

epithalamin

Development stage
Unknown
Lead developer
St. Petersburg Institute of Bioregulation and Gerontology
Modality
Peptides
Administration
Intramuscular, Oral, Subcutaneous
01

Overview

Epithalamin is a peptide bioregulator derived from the bovine pineal gland, developed by the St. Petersburg Institute of Bioregulation and Gerontology under the direction of Vladimir Khavinson. It is primarily recognized for its geroprotective properties, aimed at slowing the aging process and preventing age-associated diseases. Its synthetic analog, Epitalon (a tetrapeptide with the sequence Ala-Glu-Asp-Gly), is considered the primary active constituent. Epithalamin acts by restoring the functional activity of the pineal gland, which leads to increased endogenous melatonin secretion and normalization of circadian rhythms. Furthermore, it has been shown to activate telomerase, thereby maintaining telomere length and promoting cellular longevity. Clinical research in Russia has demonstrated its ability to improve immune function, enhance antioxidant capacity, and extend the lifespan of elderly subjects.

Brand names
Epithalamin
Other names
EpitalonEpithalonAla-Glu-Asp-GlyAEDGPineal gland peptide
02

Targets

Telomere-associated chromatinDNA

Beyond the preview

Go deeper on epithalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on epithalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call